John McGill is a seasoned professional in the field of cytogenetics and cancer diagnostics, currently serving as Director of Cytogenetics at NeoGenomics Laboratories since April 2016. Previous roles include Director of Clinical Services at Miraca Life Sciences and Caris Life Sciences, focusing on hematopathology and clinical genetics respectively. John has extensive experience as Laboratory Director at Genzyme and Genzyme Genetics, providing expertise in cancer diagnostic testing. Earlier in the career, John held leadership positions at IMPATH Inc. and the Cancer Therapy and Research Center, emphasizing cancer genetic diagnostics and research. Academic foundations include a Ph.D. in Biomedical Sciences from UT Health San Antonio and an MS in Developmental Biology from Texas State University, complemented by a BS in Biology.
This person is not in any teams
This person is not in any offices